One Cream, Growing List: How Topical JAK Inhibitors Keep Collecting Indications
Two are now approved, the indications keep expanding, and both carry a boxed warning inherited from a pill that behaves nothing like a cream.
Two are now approved, the indications keep expanding, and both carry a boxed warning inherited from a pill that behaves nothing like a cream.
The FDA's position is one sentence: there are currently no FDA-approved exosome products. Aesthetic plastic surgeons reviewing their own field reached a verdict almost as blunt.
In three years, China's share of Korea's cosmetics exports fell from roughly two-thirds to under a quarter. The products did not get worse. The assumption behind them collapsed.
US Korean skincare sales passed two billion dollars on 37% growth — driven by a channel that removed two markups and attached a commission to every recommendation you see.
Blistering in the elderly and hives that last for years now answer to the same eczema injection — which says something uncomfortable about how dermatology names things.
People stay on drugstore rotation for years to avoid a consultation — while spending more on hopeful serums than the appointment and its generic prescription would have cost.
Remote care matches in-person outcomes for the conditions it was designed around. The failure mode is not a bad connection — it is that a photograph cannot carry texture.
Visit length is not really the constraint. The constraint is that most of the visit gets spent rebuilding a treatment history you already know and nobody wrote down.
A 60-year-old diuretic is now one of dermatology's most reliable tools for adult women's jawline breakouts — so why does it still get treated like a secret?
Critics call film formers fraud and marketers call them science. Both are wrong in interesting ways — a film has real optical and occlusive function. It just is not remodelling anything, and almost nothing on the label tells you which one you bought.
Cell-cultured botanicals deliver something farming genuinely cannot — an identical compound profile in every batch. Whether they work better is a separate question the marketing keeps folding into the first.
The open-jar symbol certifies that nothing will grow in the bottle. It makes no promise at all about whether the active inside still works — and those two clocks run at completely different speeds.
It was invented to stop bleeding during surgery. In 2026 it's in dozens of brightening serums — and the evidence is better than most trend ingredients can claim.
Five brands that own the feed, judged on their ingredient lists rather than their view counts — including the one active all five suddenly added at once, and what that tells you.
The dewy-layering marketing reads as a warning if you are congested — and it is hiding the strongest mass-market lineup anywhere for exactly that skin.
It is the only mainstream format that makes reapplying sun protection over makeup genuinely easy. It is also the format most likely to be under-dosed into near-uselessness, and the physics of that are worse than they look.
Four dated case studies through the same conveyor. The pattern has repeated often enough to be predictive — which means you can evaluate the next arrival before the marketing reaches you.
Four things reorder a best-of list — the catalogue grows, a formula changes, the evidence shifts, or the engine does — and publishing that churn is more honest than freezing a page and letting it quietly rot.
It would be the most-clicked number on this site and one of the least defensible — because the data underneath it was never designed to grade a finished product.
A real mechanism, a 1976 culture experiment, a community spreadsheet and no regulator anywhere — here is exactly how much weight that badge on the bottle can carry.
The percentage on the front of the bottle is the number readers most want us to rank on, and the one number our scoring system deliberately refuses to treat as a measure of strength.
The burn trials are real and the skeptics who dismiss aloe as folklore are wrong — but the same substance has delayed healing in other wounds, and none of it says anything about what a soothing gel does to intact skin.
Chamomile's active fraction inhibits the same inflammatory pathways a steroid does, at a fraction of the strength — and the version that works best is grubbed out of Brazilian cerrado, while the synthetic substitute is half inactive by construction.
Eighteen botanicals reads as generous. Find where the preservative sits on the list and the arithmetic changes considerably.
Essential oils are declared by botanical name rather than as fragrance, which is why the most heavily perfumed products in the natural aisle can carry the reassuring word — and why the bottle gets more sensitising the longer you own it.
It turns up at the same concentration, in the same position, across an entire national industry. That is not a coincidence about biology — it is a regulation.
A large, orange, fat-soluble molecule with genuine antioxidant credentials and a delivery problem nobody solved by putting more of it in the jar.
After fifty, irritation stops being a free sample of progress and starts being a debt — which is why the right routine is a budget with a small number of well-chosen line items.
Sebum output falls by roughly a third per decade in women, which quietly invalidates the cleanser, the acid schedule and the weightless gel you picked when your face ran wet.
At one o'clock the morning's protection has degraded and there is a full face on top of it. The available answers run from genuinely useful to ritual with a label, and the ranking is not the one the marketing suggests.
Protection does not scale linearly with how much you apply. It scales as a root — which means the difference between a proper layer and your usual one is not a few points of SPF.
The critics are right about the data gap, and they are right that it took two decades to move. What follows from that is not the conclusion most people draw.
The first new American sunscreen filter since the 1990s became legal to sell yesterday. Whether any given bottle uses it well is a separate question, and the Drug Facts panel answers it.
The sense that Japanese products feel restrained and Korean ones feel inventive is not a stereotype. It is traceable to two approval systems that disagree about what a cosmetic is allowed to promise.
Japanese bottles print an instruction that Western packaging drops in translation — and skipping it is behind most of the complaints that cleansing oils leave a film, clog pores, and fail to remove sunscreen.
Western sensitive skincare works by subtraction — remove the fragrance, remove the alcohol, shorten the list. Japan's answer adds a designed molecule back in, and one of the two bets has a trial literature.
We have spent years praising Japanese filter chemistry while ignoring that the filter is the last line of a system built out of fabric, shade and timing — the part that needs no importing and does not depend on you remembering to reapply.
The rules exist. They are just different in every state, unevenly enforced, and invisible from the pavement — which is why the excellent clinic and the volume shop can charge the same price.
Two interventions genuinely prevent skin ageing, with randomised evidence behind them. Neither is the one being sold to twenty-five-year-olds — and one half of the prejuvenation pitch has no mechanism at all.
Point your phone at your face and an app 'diagnoses' your skin and — conveniently — hands you a shopping list. The computer vision is real; the objectivity often isn't.
The FDA just approved its first new sunscreen filter in a quarter-century — but it's exactly one filter, and the rest of the modern palette is still stuck at the door.
It is sold as deeply nourishing. What it measurably does is seal — and the difference decides whether you should apply it to damp skin or not at all.
That headline is the story every brand tells about trehalose. It is also, as of a 2017 paper in Molecular Cell, not quite true — which turns out to be the most interesting thing about the ingredient.
The fermentation route to skin lipids is real, industrial, and about two decades old — which makes 2026's newest ingredient claim a description of the supply chain most ceramide products already use.
Nearly every trial that made this ingredient famous ran at 2–5%. The double-digit numbers on the shelf are answering a question the biology never asked.
The mechanism is not a mystery, and knowing it tells you which men's-skincare claims are load-bearing and which are decoration.
Tumor biology explains a slice of it. The rest is where the lesion sits, who is willing to look at it, and how many months pass before anyone does.
Three dermatological clocks run at different speeds while a man decides it can wait — and one of them cannot be restarted once it stops.
Blood, pigment and shadow produce almost identical darkness in a bathroom mirror — and only one of them is a skincare problem.
Aloe has the best clinical case of any kitchen remedy — and the fresh-leaf version puts a manual processing step between you and the part that works.
Burn depth is governed by acidity and contact time, not by the percentage on the front — which makes the one number these kits print the one number that predicts nothing.
The lipid-similarity argument is the most persuasive thing anyone has said for tallow — and it points at the wrong lipids.
No trial has ever shown it produces a single new lash — and the one adverse event with its own case literature is weirder than anything on the bottle.
The one randomised trial that tested the post-workout shower rule found nothing. The mechanism it missed is mechanical, and it explains why the fix is a sequence rather than a product.
The sole is the one place on the body where a 40% keratolytic is a reasonable idea — and the one place people treat with whatever lotion is left over.
Extending a retinoid to the neck, chest and hands is worth doing — but the strength and frequency that suit your face will not survive the trip, and one of the best chest trials found the vehicle nearly kept up.
Face sunscreen is chosen on how it feels. Body sunscreen has to survive a completely different test — will you keep putting on a shot glass of it, four times a day, for a week?
The bottle contains a drug. The gesture you use on it is a hair-washing gesture, and that mismatch is the reason the flakes come back.
Seborrhoeic dermatitis and scalp psoriasis both flake, both itch, and both start at the hairline — but one answers to an antifungal and the other mostly ignores it.
Four actives run the medicated shampoo aisle, they work by three different mechanisms, and the brand name on the front tells you almost nothing about which one you just bought.
Three variables decide whether a shampoo works, and the price on the bottle correlates with none of them.
The cream aisle promises to 'erase' both. The biology says timing beats ingredients — and the honest ceiling is lower than the before-and-afters suggest.
Three of the most common facial-redness conditions get mistaken for each other — and for acne — which sends people down months of treating the wrong thing with products that make it angrier.
Those tiny dots on your nose are almost certainly not blackheads — they're normal, functional plumbing you will never 'clear,' and the extraction obsession is quietly wrecking the skin around them.
Eczema care has quietly split into two worlds: the ceramide-and-occlusion basics that manage most cases, and a new class of drugs rewriting what's possible for severe disease. Knowing which world you're in changes the whole plan.
Two are now approved, the indications keep expanding, and both carry a boxed warning inherited from a pill that behaves nothing like a cream.
Four fields on a prescription label decide whether a treatment can possibly work — strength, vehicle, quantity and refills — and patients are almost never walked through any of them.
Bespoke medicine, or four familiar actives in one jar with your name printed on it? Compounding is genuinely useful and genuinely unreviewed, and the difference matters most in the places nobody advertises.
The FDA approved the biggest reduction in isotretinoin paperwork in years, then moved the start date twice. Here is what actually changes, what does not, and the date that now matters.
The 16 largest topics above have their own rows. Everything else is one tap away here.